About Myoton

Myoton AS was established as a spin-out from the University of Tartu, Estonia, with the ambitious goal of pioneering development of soft tissues palpation technology. The company has been operating since 1999 and is currently headquartered in Tallinn, Estonia.

The founder and visionary behind the Myoton method is Dr.Arved Vain, who has devoted most of his professional career to researching and developing first technological solutions for the assessment of tone and biomechanical properties of skeletal muscles.
Years of R&D have led the company to the discovery of innovative Myoton technology that holds the promise of becoming the new widely used standard for soft tissues assessment. The company provides comprehensive technical support to researchers worldwide to support scientific studies of MyotonPRO devices in various medical and sports applications.

Myoton holds technology patents in the EPO region, US, JAP, CAN and AU.

Our Mission

Modern medicine has seen many novel solutions to help improve the quality of patient healthcare. However, there are some fields where there has been no major breakthrough, and one such field is the objective and non-invasive assessment of skeletal muscles and other soft biological tissues.

As of today, there are no solutions that are at the same time objective, non-invasive, cost-effective and accessible anytime to everyone.

Myoton has developed a solution for Digital Palpation to fill this gap for muscle and soft tissue assessment. Our mission is to develop a non-invasive and cost-effective technology for the measurement and monitoring of biological soft tissues that is consistent with the principles of preventative and evidence-based medicine. We are dedicated to leading the way to transforming how soft tissue or skeletal muscle properties are measured and monitored.